News

Agence France-Presse12m
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...
Times-Standard on MSN4m
Arcata moves forward on Annie and Mary Trail
When completed, the project will span 3.5 miles, connecting downtown Arcata north to the Valley West neighborhood via a ...